Document Detail


Reviewing non clinical data for a granulocyte colony stimulatory factor product: Experience in Brazil.
MedLine Citation:
PMID:  21784651     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Non clinical studies are one of the requirements for the Brazilian National Regulatory Authority, ANVISA, for licensing a similar biotherapeutic product. During the WHO/KFDA workshop on implementing WHO guidelines on evaluating similar biotherapeutic products (SBP) in Seoul, Republic of Korea, the Brazilian experience with the non clinical studies of a Granulocyte Colony Stimulatory Factor (G-CSF), filgrastim, was presented. The applicant presented a reduced non clinical data package, but the key studies with relevant species were conducted and the non-clinical studies were considered sufficient for approval. Using the comparability exercise, these studies were taken together with the appropriate quality and clinical packages presented.
Authors:
Laura Gomes Castanheira
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-7-22
Journal Detail:
Title:  Biologicals : journal of the International Association of Biological Standardization     Volume:  -     ISSN:  1095-8320     ISO Abbreviation:  -     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-7-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9004494     Medline TA:  Biologicals     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 The International Alliance for Biologicals. Published by Elsevier Ltd. All rights reserved.
Affiliation:
Head of Efficacy and Safety Evaluation Office, National Health Surveillance Agency (ANVISA), SIA Trecho 5, AE 57, Lote 200, Brasilia - DF, CEP 71205-050, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transformation of a vascularised iliac crest or scapula bone to a pedicled osteomuscular transplant ...
Next Document:  Biosimilars and non-innovator biotherapeutics in India: An overview of the current situation.